Price $4.35 |
Market Cap
53.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
14.7
|
P/B
3.74
|
P/S
0.26
|
Dividend %
-
|
|
P/CF
73.5
|
P/FCF
13.7
|
Op. Cash Flow
4.4K
|
FCF
0.2
|
|
Op. Margin
3.40%
|
Net Margin
1.90%
|
ROE
28.40%
|
ROI
49.80%
|
|
ROA
8.00%
|
EPS Growth
-1.00%
|
Current Ratio
1.5
|
Debt/Equity
62.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.29 | - | - | 89.6M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.46 | - | - | 4.6M | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.54 | - | - | 22.2M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $2.35 | - | - | 30M | Strong Buy |
| Genesis Healthcare Inc (GEN) | $1.84 | - | - | 287.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
